Cita APA

Molina, D., Pérez-Beteta, J., Martínez-González, A., Sepúlveda, J. M., Peralta, S., Gil-Gil, M. J., . . . Pérez-García, V. M. (2016). Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.

Citación estilo Chicago

Molina, David, et al. Geometrical Measures Obtained From Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits From Bevacizumab in Glioblastoma Patients. 2016.

Cita MLA

Molina, David, et al. Geometrical Measures Obtained From Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits From Bevacizumab in Glioblastoma Patients. 2016.